ATE512138T1 - 1h-chinolin-4-on-verbindungen mit affinität zum gaba-rezeptor, verfahren, anwendungen und zusammensetzungen - Google Patents
1h-chinolin-4-on-verbindungen mit affinität zum gaba-rezeptor, verfahren, anwendungen und zusammensetzungenInfo
- Publication number
- ATE512138T1 ATE512138T1 AT07788348T AT07788348T ATE512138T1 AT E512138 T1 ATE512138 T1 AT E512138T1 AT 07788348 T AT07788348 T AT 07788348T AT 07788348 T AT07788348 T AT 07788348T AT E512138 T1 ATE512138 T1 AT E512138T1
- Authority
- AT
- Austria
- Prior art keywords
- quinolin
- compositions
- compounds
- methods
- receptor affinity
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/04—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached to the ring carbon atoms
- C07D215/06—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached to the ring carbon atoms having only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached to the ring nitrogen atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/18—Halogen atoms or nitro radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/06—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Neurology (AREA)
- General Health & Medical Sciences (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Pain & Pain Management (AREA)
- Anesthesiology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US83666606P | 2006-08-10 | 2006-08-10 | |
EP06118720A EP1886996A1 (de) | 2006-08-10 | 2006-08-10 | 1H-Chinolin-4-on Verbindungen mit Affinität für den GABA Rezeptor, Prozesse, Verwendungen und Zusammensetzungen |
PCT/EP2007/058288 WO2008017710A1 (en) | 2006-08-10 | 2007-08-09 | 1h-quinolin-4-one compounds, with affinity for the gaba receptor, processes, uses and compositions |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE512138T1 true ATE512138T1 (de) | 2011-06-15 |
Family
ID=37651083
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT07788348T ATE512138T1 (de) | 2006-08-10 | 2007-08-09 | 1h-chinolin-4-on-verbindungen mit affinität zum gaba-rezeptor, verfahren, anwendungen und zusammensetzungen |
Country Status (13)
Country | Link |
---|---|
US (1) | US20100168099A1 (de) |
EP (1) | EP1886996A1 (de) |
CN (1) | CN101522630A (de) |
AR (1) | AR062295A1 (de) |
AT (1) | ATE512138T1 (de) |
BR (1) | BRPI0715817A2 (de) |
CL (1) | CL2007002324A1 (de) |
DK (1) | DK2064185T3 (de) |
PT (1) | PT2064185E (de) |
RU (1) | RU2009108361A (de) |
SI (1) | SI2064185T1 (de) |
TW (1) | TW200833665A (de) |
UY (1) | UY30529A1 (de) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
TWI366565B (en) | 2007-06-06 | 2012-06-21 | Otsuka Pharma Co Ltd | Quinolone compound and pharmaceutical composition |
TWI492943B (zh) | 2008-12-05 | 2015-07-21 | 大塚製藥股份有限公司 | 喹啉酮化合物及藥學組成物(二) |
JP5769504B2 (ja) * | 2010-06-04 | 2015-08-26 | 大塚製薬株式会社 | 医薬 |
SG11201404214QA (en) | 2012-02-03 | 2014-08-28 | Teva Pharma | USE OF LAQUINIMOD FOR TREATING CROHN'S DISEASE PATIENTS WHO FAILED FIRST-LINE ANTI-TNFα THERAPY |
TW201400117A (zh) | 2012-06-05 | 2014-01-01 | Teva Pharma | 使用拉喹莫德治療眼發炎疾病 |
TW201410244A (zh) | 2012-08-13 | 2014-03-16 | Teva Pharma | 用於治療gaba媒介之疾病之拉喹莫德(laquinimod) |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2728900B1 (fr) * | 1994-12-29 | 1997-01-31 | Synthelabo | Derives de 3-phenylisoquinolein-1(2h)-one, leur preparation et leur application en therapeutique |
GB9621757D0 (en) * | 1996-10-18 | 1996-12-11 | Ciba Geigy Ag | Phenyl-substituted bicyclic heterocyclyl derivatives and their use |
FR2813791B1 (fr) * | 2000-09-14 | 2004-03-12 | Lafon Labor | Utilisation de 2- et 4-quinolones pour inhiber la neo-proliferation intimale |
CA2484308A1 (en) * | 2002-05-14 | 2003-11-27 | The Regents Of The University Of California | Substituted quinolone carboxylic acids, their derivatives, site of action, and uses thereof |
-
2006
- 2006-08-10 EP EP06118720A patent/EP1886996A1/de not_active Withdrawn
-
2007
- 2007-08-06 TW TW096128818A patent/TW200833665A/zh unknown
- 2007-08-07 UY UY30529A patent/UY30529A1/es unknown
- 2007-08-09 DK DK07788348.6T patent/DK2064185T3/da active
- 2007-08-09 SI SI200730707T patent/SI2064185T1/sl unknown
- 2007-08-09 CL CL2007002324A patent/CL2007002324A1/es unknown
- 2007-08-09 CN CNA2007800365992A patent/CN101522630A/zh active Pending
- 2007-08-09 BR BRPI0715817-3A2A patent/BRPI0715817A2/pt not_active IP Right Cessation
- 2007-08-09 AR ARP070103514A patent/AR062295A1/es unknown
- 2007-08-09 PT PT07788348T patent/PT2064185E/pt unknown
- 2007-08-09 AT AT07788348T patent/ATE512138T1/de active
- 2007-08-09 US US12/377,103 patent/US20100168099A1/en not_active Abandoned
- 2007-08-09 RU RU2009108361/04A patent/RU2009108361A/ru not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
UY30529A1 (es) | 2008-02-29 |
EP1886996A1 (de) | 2008-02-13 |
RU2009108361A (ru) | 2010-09-20 |
TW200833665A (en) | 2008-08-16 |
CN101522630A (zh) | 2009-09-02 |
AR062295A1 (es) | 2008-10-29 |
PT2064185E (pt) | 2011-09-12 |
CL2007002324A1 (es) | 2008-01-18 |
SI2064185T1 (sl) | 2011-10-28 |
DK2064185T3 (da) | 2011-09-19 |
US20100168099A1 (en) | 2010-07-01 |
BRPI0715817A2 (pt) | 2014-12-23 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE602007013436D1 (de) | N-methylaminomethyl-isoindol-verbindungen und diese enthaltende zusammensetzungen und diese verwendende verfahren | |
FR2899479B1 (fr) | Composition cicatrisante | |
DE602009000202D1 (de) | Positive Resistzusammensetzung und Strukturierungsverfahren | |
DK2014652T3 (da) | Aktiveringsmiddel til peroxisom-proliferator-aktiveret receptor | |
IL192789A0 (en) | Stabilizer composition for polymers | |
EP2078400A4 (de) | Dtf-spreiz-ofdm | |
BRPI0809690A2 (pt) | Composição de lubrificante, e, método | |
FR2921069B1 (fr) | Composition polyamide | |
BRPI0809573A8 (pt) | composição, e, método | |
BRPI0716458A2 (pt) | Composição de vulcanizado | |
DE602007001706D1 (de) | Tonerzusammensetzung und Verfahren | |
HK1131523A1 (en) | Clip for wig | |
DE502007005744D1 (de) | Schallgedämpftes, gasführendes Bauteil | |
EP2015765A4 (de) | Verfahren und zusammensetzungen zur behandlung von erkrankungen | |
BRPI0814167A2 (pt) | Composição, e, método | |
DE602007012648D1 (de) | Härtbare Zusammensetzung | |
DE602007004820D1 (de) | Härtbare Zusammensetzung | |
EP2019836A4 (de) | Verfahren, zusammensetzungen und kits für den nachweis von proteinaggregaten | |
DE602006005232D1 (de) | Konzentrierte Esterquat-zusammensetzung | |
BRPI0821249A2 (pt) | Composição de endurecimento | |
BRPI0814748A2 (pt) | Compostos de alditóis substituídos, composições e métodos | |
ATE512138T1 (de) | 1h-chinolin-4-on-verbindungen mit affinität zum gaba-rezeptor, verfahren, anwendungen und zusammensetzungen | |
DK1986508T3 (da) | Fremgangsmåder og sammensætninger til behandling af felin hyperthyroidisme | |
EP2042556A4 (de) | Polyamidzusammensetzung | |
DE502006002572D1 (de) | Bauteilreparaturverfahren |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
UEP | Publication of translation of european patent specification |
Ref document number: 2064185 Country of ref document: EP |